10X Genomics filed its required 13F reports with the Securities and Exchange Commission and its stock continues to trade on the Nasdaq exchange.
6 reports, 3 independent
Updated Aug 10
Gone quiet
- Reports
- 6
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
10X Genomics filed its required 13F reports with the Securities and Exchange Commission and its stock continues to trade on the Nasdaq exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.10X Genomics reported a 27.0% stake reduction in Q1 via SEC filing.1 source
10X Genomics filed 13F reports with the SEC and its stock trades on the Nasdaq.1 source
Keep exploring
The entities involved
-
10X Genomics
American biotechnology company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
-
Nasdaq
American fully electronic stock exchange